ATE264690T1 - Unlöslisches insulin zusammensetzungen für regelung der blutglukose - Google Patents
Unlöslisches insulin zusammensetzungen für regelung der blutglukoseInfo
- Publication number
- ATE264690T1 ATE264690T1 AT98310695T AT98310695T ATE264690T1 AT E264690 T1 ATE264690 T1 AT E264690T1 AT 98310695 T AT98310695 T AT 98310695T AT 98310695 T AT98310695 T AT 98310695T AT E264690 T1 ATE264690 T1 AT E264690T1
- Authority
- AT
- Austria
- Prior art keywords
- regulation
- blood glucose
- insulin compositions
- insoluble insulin
- insoluble
- Prior art date
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title 1
- 102000004877 Insulin Human genes 0.000 title 1
- 108090001061 Insulin Proteins 0.000 title 1
- 239000008280 blood Substances 0.000 title 1
- 210000004369 blood Anatomy 0.000 title 1
- 239000008103 glucose Substances 0.000 title 1
- 229940125396 insulin Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6860197P | 1997-12-23 | 1997-12-23 | |
| US8885998P | 1998-06-11 | 1998-06-11 | |
| US10994098P | 1998-11-25 | 1998-11-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE264690T1 true ATE264690T1 (de) | 2004-05-15 |
Family
ID=27371371
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98310695T ATE264690T1 (de) | 1997-12-23 | 1998-12-23 | Unlöslisches insulin zusammensetzungen für regelung der blutglukose |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US6531448B1 (de) |
| EP (1) | EP0925792B1 (de) |
| JP (1) | JP2001526225A (de) |
| KR (1) | KR20010024799A (de) |
| CN (1) | CN1284876A (de) |
| AR (1) | AR019807A1 (de) |
| AT (1) | ATE264690T1 (de) |
| AU (1) | AU2008899A (de) |
| BR (1) | BR9814471A (de) |
| CA (1) | CA2315300A1 (de) |
| CO (1) | CO4970787A1 (de) |
| DE (1) | DE69823319D1 (de) |
| DZ (1) | DZ2691A1 (de) |
| EA (1) | EA003394B1 (de) |
| HR (1) | HRP20000427A2 (de) |
| HU (1) | HUP0100243A3 (de) |
| ID (1) | ID25476A (de) |
| IL (1) | IL136724A0 (de) |
| NO (1) | NO20003269L (de) |
| NZ (1) | NZ505091A (de) |
| PE (1) | PE20000106A1 (de) |
| PL (1) | PL341300A1 (de) |
| TR (1) | TR200001935T2 (de) |
| WO (1) | WO1999032116A1 (de) |
Families Citing this family (67)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0911035A3 (de) * | 1997-10-24 | 2002-08-21 | Eli Lilly And Company | Unlösliche insulinzusammensetzungen |
| US6531448B1 (en) * | 1997-12-23 | 2003-03-11 | Eli Lilly And Company | Insoluble compositions for controlling blood glucose |
| US6734162B2 (en) | 2000-01-24 | 2004-05-11 | Minimed Inc. | Mixed buffer system for stabilizing polypeptide formulations |
| US6737401B2 (en) | 2001-06-28 | 2004-05-18 | Metronic Minimed, Inc. | Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom |
| EP1432430A4 (de) | 2001-08-28 | 2006-05-10 | Lilly Co Eli | Vormischungen von glp-1 und basalinsulin |
| MXPA04003569A (es) | 2001-10-19 | 2004-07-23 | Lilly Co Eli | Mezclas bifasicas de glp-1 e insulina. |
| AU2002346491A1 (en) * | 2001-12-19 | 2003-07-09 | Eli Lilly And Company | Crystalline compositions for controlling blood glucose |
| AU2002359730A1 (en) * | 2001-12-21 | 2003-07-30 | Smithkline Beecham Corporation | Compositions and methods for altering glucose production |
| JP5599543B2 (ja) | 2002-05-07 | 2014-10-01 | ノヴォ ノルディスク アー／エス | 単量体インスリン及びアシル化インスリンを含む可溶性製剤 |
| RU2357750C2 (ru) | 2002-12-31 | 2009-06-10 | Элтус Фармасьютикалз Инк. | Кристаллы человеческого гормона роста и способы их получения |
| WO2004080481A1 (en) * | 2003-03-13 | 2004-09-23 | Novo Nordisk A/S | Novel nph insulin preparations |
| EP1620465A2 (de) * | 2003-04-29 | 2006-02-01 | Eli Lilly And Company | Insulin-analoge mit zeitverzögerter wirkung |
| US20050054818A1 (en) * | 2003-07-02 | 2005-03-10 | Brader Mark Laurence | Crystalline compositions for controlling blood glucose |
| CA2531988C (en) * | 2003-08-05 | 2016-06-28 | Novo Nordisk A/S | Novel insulin derivatives |
| AU2014200247B2 (en) * | 2004-07-19 | 2015-05-14 | Biocon Limited | Insulin-oligomer conjugates, formulations and uses thereof |
| RU2527893C2 (ru) * | 2004-07-19 | 2014-09-10 | Биокон Лимитед | Инсулин-олигомерные конъюгаты, их препараты и применения |
| PL373543A1 (pl) * | 2005-03-10 | 2006-09-18 | Instytut Biotechnologii i Antybiotyków | Kompozycja farmaceutyczna zawierająca biosyntetyczny analog insuliny ludzkiej, oraz jej zastosowanie w terapii cukrzycy |
| AU2006295340B2 (en) | 2005-08-05 | 2010-11-11 | Amgen Inc. | Stable aqueous protein or antibody pharmaceutical formulations and their preparation |
| KR101067266B1 (ko) * | 2005-08-29 | 2011-09-23 | 아지노모토 가부시키가이샤 | 영양 조성물 |
| ES2371361T3 (es) * | 2005-12-28 | 2011-12-30 | Novo Nordisk A/S | Composiciones que comprenden una insulina acilada y zinc y método de producción de dichas composiciones. |
| WO2007081824A2 (en) * | 2006-01-06 | 2007-07-19 | Case Western Reserve University | Fibrillation resistant proteins |
| WO2007121318A2 (en) * | 2006-04-12 | 2007-10-25 | Emisphere Technologies, Inc. | Formulations for delivering insulin |
| CN101573133B (zh) | 2006-07-31 | 2014-08-27 | 诺沃-诺迪斯克有限公司 | Peg化延长的胰岛素 |
| RU2524150C2 (ru) | 2006-09-22 | 2014-07-27 | Ново Нордиск А/С | Аналоги инсулина, устойчивые к протеазам |
| WO2008043033A2 (en) | 2006-10-04 | 2008-04-10 | Case Western Reserve University | Fibrillation-resistant insulin and insulin analogues |
| JP5496082B2 (ja) | 2007-04-30 | 2014-05-21 | ノボ・ノルデイスク・エー／エス | タンパク質組成物を乾燥させる方法、乾燥タンパク質組成物、及び乾燥タンパク質を含有する薬学的組成物 |
| JP5552046B2 (ja) * | 2007-06-13 | 2014-07-16 | ノボ・ノルデイスク・エー／エス | インスリン誘導体を含有する薬学的製剤 |
| RU2453332C2 (ru) * | 2007-10-16 | 2012-06-20 | Байокон Лимитид | Твердая фармацевтическая композиция (варианты) и способ контроля концентрации глюкозы с ее помощью, способ получения твердой фармацевтической композиции (варианты), таблетка (варианты) и способ получения амфорных частиц |
| BRPI0820535B8 (pt) | 2007-11-16 | 2021-05-25 | Novo Nordisk As | composições farmacêuticas contendo insulina e um peptídeo insulinotrópico |
| WO2009112583A2 (en) | 2008-03-14 | 2009-09-17 | Novo Nordisk A/S | Protease-stabilized insulin analogues |
| HUE032284T2 (en) | 2008-03-18 | 2017-09-28 | Novo Nordisk As | Protease-stabilized, acylated insulin analogues |
| JP2011516541A (ja) * | 2008-04-07 | 2011-05-26 | ナショナル インスティテュート オブ イミュノロジー | 糖尿病および他の慢性疾患の治療に有用な組成物 |
| US8993516B2 (en) * | 2008-04-14 | 2015-03-31 | Case Western Reserve University | Meal-time insulin analogues of enhanced stability |
| EP2296692A4 (de) * | 2008-04-22 | 2012-06-06 | Univ Case Western Reserve | Isoform-spezifische insulinanaloga |
| US9200053B2 (en) | 2008-07-31 | 2015-12-01 | Case Western Reserve University | Insulin analogues containing penta-fluoro-Phenylalanine at position B24 |
| KR20120129875A (ko) * | 2008-07-31 | 2012-11-28 | 케이스 웨스턴 리저브 유니버시티 | 염소화 아미노산을 갖는 인슐린 유사체 |
| EP2344200A2 (de) * | 2008-09-19 | 2011-07-20 | Nektar Therapeutics | Modifizierte therapeutische peptide, herstellungsverfahren und verwendung |
| JP4959005B2 (ja) * | 2008-10-30 | 2012-06-20 | ノボ・ノルデイスク・エー／エス | 毎日の注射頻度より少ないインスリン注射での真性糖尿病の治療 |
| US8399407B2 (en) * | 2009-09-17 | 2013-03-19 | Case Western Reserve University | Non-standard insulin analogues |
| WO2011064316A2 (en) | 2009-11-25 | 2011-06-03 | Paolo Botti | Mucosal delivery of peptides |
| AU2010327949A1 (en) | 2009-12-11 | 2012-06-28 | Case Western Reserve University | Insulin analogues with chlorinated amino acids |
| DK2632478T3 (da) | 2010-10-27 | 2019-10-07 | Novo Nordisk As | Behandling af diabetes melitus under anvendelse af insulinindsprøjtninger indgivet med varierende indsprøjtningsintervaller |
| CN102219851B (zh) * | 2011-05-09 | 2012-05-30 | 甘李药业有限公司 | 甘精胰岛素结晶的制备方法 |
| CN103596584B (zh) * | 2011-06-15 | 2016-12-14 | 诺沃—诺迪斯克有限公司 | 多取代的胰岛素 |
| WO2014096985A2 (en) * | 2012-12-19 | 2014-06-26 | Wockhardt Limited | A stable aqueous composition comprising human insulin or an analogue or derivative thereof |
| CN104364260B (zh) | 2012-04-11 | 2017-02-22 | 诺和诺德股份有限公司 | 胰岛素制剂 |
| DE112013002122T5 (de) | 2012-04-18 | 2014-12-31 | Waters Technologies Corporation | Verfahren zur Quantifizierung von Polypeptiden mittels Massenspektrometrie |
| EP2844274B1 (de) | 2012-05-01 | 2019-03-20 | Novo Nordisk A/S | Pharmazeutische zusammensetzung |
| US9897565B1 (en) | 2012-09-11 | 2018-02-20 | Aseko, Inc. | System and method for optimizing insulin dosages for diabetic subjects |
| US9171343B1 (en) | 2012-09-11 | 2015-10-27 | Aseko, Inc. | Means and method for improved glycemic control for diabetic patients |
| US10421795B2 (en) | 2012-12-17 | 2019-09-24 | Merck Sharp & Dohme Corp. | Process for purifying insulin and analogues thereof |
| US9725493B2 (en) * | 2013-01-22 | 2017-08-08 | Case Western Reserve University | N-terminal truncated insulin analogues |
| CN103145829B (zh) * | 2013-03-29 | 2015-06-03 | 江苏诺泰制药有限公司 | 一种地特胰岛素的纯化方法 |
| EP2991672A1 (de) | 2013-04-30 | 2016-03-09 | Novo Nordisk A/S | Neuartiges verabreichungsschema |
| JP6499184B2 (ja) | 2013-10-07 | 2019-04-10 | ノヴォ ノルディスク アー／エス | インスリン類似体の新規な誘導体 |
| US9486580B2 (en) | 2014-01-31 | 2016-11-08 | Aseko, Inc. | Insulin management |
| US9898585B2 (en) | 2014-01-31 | 2018-02-20 | Aseko, Inc. | Method and system for insulin management |
| AR099569A1 (es) | 2014-02-28 | 2016-08-03 | Novo Nordisk As | Derivados de insulina y los usos médicos de estos |
| BR112017004544A2 (pt) | 2014-10-06 | 2018-01-23 | Univ Case Western Reserve | insulina de cadeia simples, composição farmacêutica e método para tratar diabetes mellitus |
| US11081226B2 (en) | 2014-10-27 | 2021-08-03 | Aseko, Inc. | Method and controller for administering recommended insulin dosages to a patient |
| AU2015339576B2 (en) | 2014-10-27 | 2020-02-06 | Glytec, Llc | Subcutaneous outpatient management |
| WO2017031440A1 (en) | 2015-08-20 | 2017-02-23 | Aseko, Inc. | Diabetes management therapy advisor |
| PE20210857A1 (es) | 2016-12-16 | 2021-05-18 | Novo Nordisk As | Composiciones farmaceuticas que contienen insulina |
| US10335464B1 (en) | 2018-06-26 | 2019-07-02 | Novo Nordisk A/S | Device for titrating basal insulin |
| US12343383B2 (en) | 2019-07-12 | 2025-07-01 | Novo Nordisk A/S | High concentration insulin formulation |
| KR102253318B1 (ko) * | 2020-06-02 | 2021-05-18 | (주)위바이오트리 | 금속 상 변환 화합물 및 이의 제조 방법 |
| CN114306577B (zh) * | 2020-10-10 | 2024-04-09 | 南京汉欣医药科技有限公司 | 一种门冬胰岛素30混悬液的制备方法 |
Family Cites Families (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2538018A (en) | 1944-04-04 | 1951-01-16 | Nordisk Insulinlab | Crystalline product of insulin and alkaline protein and process of making it |
| US2801953A (en) | 1952-02-28 | 1957-08-06 | Hoechst Ag | Process of preparing crystallized insulin preparations |
| US2849370A (en) | 1953-06-04 | 1958-08-26 | Novo Terapeutisk Labortorium A | Injectable insulin preparations with protracted effect and process of producing same |
| US3102077A (en) | 1953-08-19 | 1963-08-27 | Christensen Henry Marinus | Preparation of insulin containing 2.75 to 8 percent zinc content |
| US3060093A (en) | 1957-07-18 | 1962-10-23 | Nordisk Insulinlab | Slowly acting insulin preparation in crystalline form and method of preparation |
| US3012077A (en) * | 1960-03-11 | 1961-12-05 | Union Carbide Corp | Process for the production of organo sulfur compounds |
| DE1793517C3 (de) | 1968-09-28 | 1974-12-05 | Farbwerke Hoechst Ag, Vormals Meister Lucius & Bruening, 6000 Frankfurt | N(Al),N(B29>Bis-(tert.-butyloxycarbonyl)-insulin und Verfahren zu seiner Herstellung |
| US3950517A (en) | 1970-05-08 | 1976-04-13 | National Research Development Corporation | Insulin derivatives |
| US3869437A (en) | 1970-05-08 | 1975-03-04 | Nat Res Dev | Mono-, di, and N{HD A1{B , N{HU B1{B , N{HU B29{B -tri-acylated insulin |
| GB1381274A (en) | 1971-01-28 | 1975-01-22 | Nat Res Dev | Insulin derivatives |
| US3868358A (en) | 1971-04-30 | 1975-02-25 | Lilly Co Eli | Protamine-insulin product |
| US3864325A (en) | 1971-11-18 | 1975-02-04 | Nat Res Dev | (N{HU Al{b , N{HU Bl{b , N{HU B29{B , carbamoyl)-(O{HU A14{B , O{HU B16{B , O{HU B26{B aryl) insulin derivatives |
| US3907763A (en) | 1972-03-01 | 1975-09-23 | Bayer Ag | Insulin derivatives crosslinked by a dicarboxylic acid moiety |
| US4183849A (en) | 1975-01-15 | 1980-01-15 | Nordisk Insulinlaboratorium | Therapeutic insulin preparation and a process for the production of a stable insulin preparation with protracted effect |
| JPS55138391A (en) | 1979-04-13 | 1980-10-29 | Shionogi & Co Ltd | New synthetic method of peptide derivative |
| JPS55138393A (en) | 1979-04-13 | 1980-10-29 | Shionogi & Co Ltd | Semisynthesis of insulin |
| IE50892B1 (en) | 1980-02-11 | 1986-08-06 | Novo Industri As | Process for preparing insulin esters |
| DE3101382A1 (de) | 1981-01-17 | 1982-09-02 | Hoechst Ag, 6000 Frankfurt | "verfahren zur herstellung von humanisulin oder dessen derivaten aus schweineinsulin oder dessen derivaten" |
| DK353781A (da) | 1981-08-10 | 1983-02-11 | Novo Industri As | Fremgangsmaade til fremstilling af insulinderivater |
| AU551174B2 (en) | 1981-09-15 | 1986-04-17 | Nordisk Insulinlaboratorium | Enzymatic preparation of human insulin or b-30 esters thereof |
| DE3326473A1 (de) | 1983-07-22 | 1985-01-31 | Hoechst Ag, 6230 Frankfurt | Pharmazeutisches mittel zur behandlung des diabetes mellitus |
| DE3327709A1 (de) | 1983-07-29 | 1985-02-07 | Hoechst Ag, 6230 Frankfurt | Insulin-derivat-kristallsuspensionen, verfahren zu deren herstellung und deren verwendung |
| PH25772A (en) | 1985-08-30 | 1991-10-18 | Novo Industri As | Insulin analogues, process for their preparation |
| DE3717370A1 (de) | 1987-05-22 | 1988-12-01 | Hoechst Ag | Mischkristalle aus insulin und insulinderivaten, verfahren zur herstellung dieser mischkristalle, diese mischkristalle enthaltende pharmazeutische mittel und ihre verwendung zur behandlung von diabetes mellitus |
| JPH01254699A (ja) | 1988-04-05 | 1989-10-11 | Kodama Kk | インスリン誘導体及びその用途 |
| JPH03506023A (ja) | 1988-07-20 | 1991-12-26 | ノボ ノルデイスク アクツイエセルスカプ | ポリペプチド |
| HUT56857A (en) | 1988-12-23 | 1991-10-28 | Novo Nordisk As | Human insulin analogues |
| US5514646A (en) | 1989-02-09 | 1996-05-07 | Chance; Ronald E. | Insulin analogs modified at position 29 of the B chain |
| IL93282A (en) | 1989-02-09 | 1995-08-31 | Lilly Co Eli | Insulin analogues |
| DK134189D0 (da) | 1989-03-20 | 1989-03-20 | Nordisk Gentofte | Insulinforbindelser |
| AT400337B (de) * | 1990-05-02 | 1995-12-27 | Plasser Bahnbaumasch Franz | Gleisstopfmaschine mit in gleisquerrichtung verstellbaren stopfeinheiten |
| JP2837956B2 (ja) | 1993-06-21 | 1998-12-16 | ノボ ノルディスク アクティーゼルスカブ | Ａｓｐ▲上Ｂ２８▼インスリン結晶 |
| DK72793D0 (da) | 1993-06-21 | 1993-06-21 | Novo Nordisk As | Nyt produkt |
| US5534488A (en) * | 1993-08-13 | 1996-07-09 | Eli Lilly And Company | Insulin formulation |
| EP1132404A3 (de) | 1993-09-17 | 2002-03-27 | Novo Nordisk A/S | Acyliertes Insulin |
| US5461031A (en) | 1994-06-16 | 1995-10-24 | Eli Lilly And Company | Monomeric insulin analog formulations |
| US5474978A (en) | 1994-06-16 | 1995-12-12 | Eli Lilly And Company | Insulin analog formulations |
| US5597893A (en) | 1994-10-31 | 1997-01-28 | Eli Lilly And Company | Preparation of stable insulin analog crystals |
| CZ289343B6 (cs) | 1995-03-17 | 2002-01-16 | Novo Nordisk A/S | Inzulinový derivát a farmaceutický prostředek pro léčení diabetes |
| US5700904A (en) | 1995-06-07 | 1997-12-23 | Eli Lilly And Company | Preparation of an acylated protein powder |
| US5877153A (en) | 1996-06-11 | 1999-03-02 | Commonwealth Biotechnologies Inc. | Heparin-binding peptides |
| EP0910402B1 (de) | 1996-06-20 | 2007-08-08 | Novo Nordisk A/S | INSULINPREPARATION MIT MAnnitol |
| US5948751A (en) | 1996-06-20 | 1999-09-07 | Novo Nordisk A/S | X14-mannitol |
| ATE294189T1 (de) | 1997-02-07 | 2005-05-15 | Novo Nordisk As | Kristallisation von proteinen |
| US5898028A (en) | 1997-03-20 | 1999-04-27 | Novo Nordisk A/S | Method for producing powder formulation comprising an insulin |
| JP2001521006A (ja) | 1997-10-24 | 2001-11-06 | イーライ・リリー・アンド・カンパニー | 不溶性インシュリン組成物 |
| ZA989744B (en) | 1997-10-31 | 2000-04-26 | Lilly Co Eli | Method for administering acylated insulin. |
| US6531448B1 (en) * | 1997-12-23 | 2003-03-11 | Eli Lilly And Company | Insoluble compositions for controlling blood glucose |
-
1998
- 1998-12-21 US US09/217,275 patent/US6531448B1/en not_active Expired - Fee Related
- 1998-12-21 CO CO98075716A patent/CO4970787A1/es unknown
- 1998-12-22 HR HR20000427A patent/HRP20000427A2/hr not_active Application Discontinuation
- 1998-12-22 IL IL13672498A patent/IL136724A0/xx unknown
- 1998-12-22 BR BR9814471-5A patent/BR9814471A/pt not_active IP Right Cessation
- 1998-12-22 AR ARP980106619A patent/AR019807A1/es unknown
- 1998-12-22 JP JP2000525107A patent/JP2001526225A/ja not_active Withdrawn
- 1998-12-22 TR TR2000/01935T patent/TR200001935T2/xx unknown
- 1998-12-22 DZ DZ980301A patent/DZ2691A1/xx active
- 1998-12-22 KR KR1020007006946A patent/KR20010024799A/ko not_active Withdrawn
- 1998-12-22 PE PE1998001271A patent/PE20000106A1/es not_active Application Discontinuation
- 1998-12-22 WO PCT/US1998/027299 patent/WO1999032116A1/en not_active Ceased
- 1998-12-22 AU AU20088/99A patent/AU2008899A/en not_active Abandoned
- 1998-12-22 ID IDW20001227A patent/ID25476A/id unknown
- 1998-12-22 CN CN98813743A patent/CN1284876A/zh active Pending
- 1998-12-22 CA CA002315300A patent/CA2315300A1/en not_active Abandoned
- 1998-12-22 PL PL98341300A patent/PL341300A1/xx unknown
- 1998-12-22 EA EA200000708A patent/EA003394B1/ru not_active IP Right Cessation
- 1998-12-22 HU HU0100243A patent/HUP0100243A3/hu unknown
- 1998-12-22 NZ NZ505091A patent/NZ505091A/xx unknown
- 1998-12-23 EP EP98310695A patent/EP0925792B1/de not_active Expired - Lifetime
- 1998-12-23 AT AT98310695T patent/ATE264690T1/de not_active IP Right Cessation
- 1998-12-23 DE DE69823319T patent/DE69823319D1/de not_active Expired - Lifetime
-
2000
- 2000-06-22 NO NO20003269A patent/NO20003269L/no not_active Application Discontinuation
-
2003
- 2003-01-07 US US10/338,101 patent/US20030144181A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0100243A3 (en) | 2001-09-28 |
| EP0925792A2 (de) | 1999-06-30 |
| IL136724A0 (en) | 2001-06-14 |
| CO4970787A1 (es) | 2000-11-07 |
| ID25476A (id) | 2000-10-05 |
| WO1999032116A1 (en) | 1999-07-01 |
| US20030144181A1 (en) | 2003-07-31 |
| AR019807A1 (es) | 2002-03-20 |
| KR20010024799A (ko) | 2001-03-26 |
| CA2315300A1 (en) | 1999-07-01 |
| JP2001526225A (ja) | 2001-12-18 |
| CN1284876A (zh) | 2001-02-21 |
| PL341300A1 (en) | 2001-04-09 |
| TR200001935T2 (tr) | 2000-12-21 |
| BR9814471A (pt) | 2000-10-10 |
| EA003394B1 (ru) | 2003-04-24 |
| EP0925792A3 (de) | 2001-09-12 |
| NZ505091A (en) | 2002-11-26 |
| HRP20000427A2 (en) | 2001-06-30 |
| PE20000106A1 (es) | 2000-02-09 |
| US6531448B1 (en) | 2003-03-11 |
| NO20003269D0 (no) | 2000-06-22 |
| AU2008899A (en) | 1999-07-12 |
| DE69823319D1 (de) | 2004-05-27 |
| EP0925792B1 (de) | 2004-04-21 |
| HUP0100243A2 (hu) | 2001-08-28 |
| DZ2691A1 (fr) | 2003-03-29 |
| NO20003269L (no) | 2000-08-23 |
| EA200000708A1 (ru) | 2000-12-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE264690T1 (de) | Unlöslisches insulin zusammensetzungen für regelung der blutglukose | |
| NO20002038D0 (no) | Uløselig insulinsammensetning | |
| FI972292A0 (fi) | Administrering av diabetes | |
| DE69829554D1 (de) | Ovalgefortme herzkanüle | |
| ITMI951278A0 (it) | Formulazioni di analoghi dell'insulina | |
| DK0730864T3 (da) | Lægemiddel til behandling af inflammatoriske hjertesygdomme | |
| ATE289212T1 (de) | Phiole für implantat | |
| IT1276722B1 (it) | Formulazioni di analoghi monomerici dell'insulina | |
| ID25757A (id) | Strip untuk uji glukosa darah secara visual | |
| AU2585799A (en) | Non-invasive optical measurement of blood hematocrit | |
| AU3876499A (en) | Non-invasive measurement of blood glucose | |
| DE60039515D1 (de) | Zusammensetzung für ersatz für knochentransplantat | |
| DK1093370T3 (da) | Farmaceutisk præparat til behandling af diabetes | |
| DE69827328D1 (de) | Vormontierte Spritze | |
| FI952930A7 (fi) | Pysyvien sinkki-insuliinianalogikiteiden valmistaminen | |
| MX224819B (es) | Empleo cosmetico de derivados de bis(resorcinil)triacina. | |
| PL337992A1 (en) | Fungicidal compositions containing derivatives of phenylacrylic acid | |
| NO20003105D0 (no) | Fenylaminoalkylkarboksylsyre-derivater samt medisinske sammensetninger omfattende slike | |
| DE69820889D1 (de) | Leitung für medizinische Zwecke | |
| DE69925307D1 (de) | Verwendung von unverseifbaren pflanzlichen ölen für die herstellung pharmazeutischer präparate | |
| AU5780398A (en) | Pharmaceutical composition for treatment of heart disease based on cardiac hypertrophy | |
| DE59811963D1 (de) | Exoprothese für das menschliche kniegelenk | |
| IT1302693B1 (it) | Procedimento per il risanamento degli argini | |
| ZA9811728B (en) | Insoluble compositions for controlling blood glucose. | |
| KR960008736U (ko) | 섬프히터(Sump Heater)의 결합구조 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |